145 related articles for article (PubMed ID: 37387099)
21. Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis.
Smith MJ; Kulkarni A; Rustad C; Bowers NL; Wallace AJ; Holder SE; Heiberg A; Ramsden RT; Evans DG
Am J Med Genet A; 2012 Jan; 158A(1):215-9. PubMed ID: 22105938
[TBL] [Abstract][Full Text] [Related]
22. The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.
Kehrer-Sawatzki H; Farschtschi S; Mautner VF; Cooper DN
Hum Genet; 2017 Feb; 136(2):129-148. PubMed ID: 27921248
[TBL] [Abstract][Full Text] [Related]
23. Updated protocol for genetic testing, screening and clinical management of individuals at risk of NF2-related schwannomatosis.
Halliday D; Emmanouil B; Evans DGR
Clin Genet; 2023 May; 103(5):540-552. PubMed ID: 36762955
[TBL] [Abstract][Full Text] [Related]
24. Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis.
Smith MJ; Bowers NL; Bulman M; Gokhale C; Wallace AJ; King AT; Lloyd SK; Rutherford SA; Hammerbeck-Ward CL; Freeman SR; Evans DG
Neurology; 2017 Jan; 88(1):87-92. PubMed ID: 27856782
[TBL] [Abstract][Full Text] [Related]
25. Genetic testing to gain diagnostic clarity in neurofibromatosis type 2 and schwannomatosis.
Burns R; Niendorf K; Steinberg K; Mueller A; Ly I; Jordan JT; Plotkin SR; Hicks SR
Am J Med Genet A; 2022 Aug; 188(8):2413-2420. PubMed ID: 35638454
[TBL] [Abstract][Full Text] [Related]
26. Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?
Seppälä MT; Sainio MA; Haltia MJ; Kinnunen JJ; Setälä KH; Jääskeläinen JE
J Neurosurg; 1998 Jul; 89(1):36-41. PubMed ID: 9647170
[TBL] [Abstract][Full Text] [Related]
27. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas.
Antinheimo J; Sankila R; Carpén O; Pukkala E; Sainio M; Jääskeläinen J
Neurology; 2000 Jan; 54(1):71-6. PubMed ID: 10636128
[TBL] [Abstract][Full Text] [Related]
28. SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors.
Smith MJ; Wallace AJ; Bowers NL; Eaton H; Evans DG
Cancer Genet; 2014 Sep; 207(9):373-8. PubMed ID: 24933152
[TBL] [Abstract][Full Text] [Related]
29. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders.
Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Druker H; Scott HS; Tabori U
Clin Cancer Res; 2017 Jun; 23(12):e54-e61. PubMed ID: 28620005
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.
Jacoby LB; Jones D; Davis K; Kronn D; Short MP; Gusella J; MacCollin M
Am J Hum Genet; 1997 Dec; 61(6):1293-302. PubMed ID: 9399891
[TBL] [Abstract][Full Text] [Related]
31. Management of neurofibromatosis type 2 and schwannomatosis associated peripheral and intraspinal schwannomas: influence of surgery, genetics, and localization.
Gugel I; Grimm F; Tatagiba M; Schuhmann MU; Zipfel J
J Neurooncol; 2022 Sep; 159(2):271-279. PubMed ID: 35771312
[TBL] [Abstract][Full Text] [Related]
32. [Seizures in neurofibromatosis. What is the risk?].
Drouet A
Rev Neurol (Paris); 2011 Dec; 167(12):886-96. PubMed ID: 22041820
[TBL] [Abstract][Full Text] [Related]
33. Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis.
Merker VL; Dai A; Radtke HB; Knight P; Jordan JT; Plotkin SR
BMC Health Serv Res; 2018 Aug; 18(1):668. PubMed ID: 30157837
[TBL] [Abstract][Full Text] [Related]
34. Distinctive low epidermal nerve fiber density in schwannomatosis patients provides a major parameter for diagnosis and differential diagnosis.
Farschtschi SC; Kluwe L; Schön G; Friedrich RE; Matschke J; Glatzel M; Weis J; Hagel C; Mautner VF
Brain Pathol; 2020 Mar; 30(2):386-391. PubMed ID: 31424590
[TBL] [Abstract][Full Text] [Related]
35. Neurofibromatosis type 2 (NF 2) or schwannomatosis?--Case report study and diagnostic criteria.
Radek M; Tomasik B; Wojdyn M; Snopkowska-Wiaderna D; Błaszczyk M; Radek A
Neurol Neurochir Pol; 2016; 50(3):219-25. PubMed ID: 27154453
[TBL] [Abstract][Full Text] [Related]
36. Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2.
Buckley PG; Mantripragada KK; Díaz de Ståhl T; Piotrowski A; Hansson CM; Kiss H; Vetrie D; Ernberg IT; Nordenskjöld M; Bolund L; Sainio M; Rouleau GA; Niimura M; Wallace AJ; Evans DG; Grigelionis G; Menzel U; Dumanski JP
Hum Mutat; 2005 Dec; 26(6):540-9. PubMed ID: 16287142
[TBL] [Abstract][Full Text] [Related]
37. Pathogenic noncoding variants in the neurofibromatosis and schwannomatosis predisposition genes.
Perez-Becerril C; Evans DG; Smith MJ
Hum Mutat; 2021 Oct; 42(10):1187-1207. PubMed ID: 34273915
[TBL] [Abstract][Full Text] [Related]
38. The neurofibromatoses. Part 2: NF2 and schwannomatosis.
Lu-Emerson C; Plotkin SR
Rev Neurol Dis; 2009; 6(3):E81-6. PubMed ID: 19898272
[TBL] [Abstract][Full Text] [Related]
39. [Neurofibromatosis].
Wolkenstein P; Decq P
Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
[TBL] [Abstract][Full Text] [Related]
40. [Familial schwannomatosis, a new entity distinct from neurofibromatosis type 1 and 2].
Reinders JW; Koehler PJ
Ned Tijdschr Geneeskd; 2007 Aug; 151(34):1891-5. PubMed ID: 17902564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
